New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 8, 2014
08:58 EDTSNTA, PNT, PPHMThree pharma companies have good partnering prospects, says Roth Capital
Roth Capital believes that Peregrine (PPHM), Palatin (PTN), and Synta (SNTA) have good odds of signing partnership deals in the "relative near term." The firm keeps Buy ratings on all three stocks.
News For PPHM;PNT;SNTA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
August 26, 2015
09:04 EDTPPHMPeregrine presents bavituximab data showing estimated survival curves at plateau
Subscribe for More Information
August 24, 2015
09:18 EDTPPHMOn The Fly: Pre-market Movers
Subscribe for More Information
05:13 EDTPPHMAstraZeneca to collaborate with Peregrine on cancer immunotherapy clinical trial
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use